Letter by Jin-shan and Xue-bin Regarding Article, “Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with great interest the article by Hoffmann and colleagues1 about the prognostic value of noninvasive cardiovascular testing in patients with stable chest pain. The article indicates that coronary computed tomography angiography (CTA) provides better prognostic information than functional testing in contemporary patients who have stable chest pain with a low burden of obstructive coronary artery disease, myocardial ischemia, and events. CTA operates by identifying patients …